Swiss Life Asset Management Ltd Has $13.64 Million Stock Holdings in HCA Healthcare, Inc. $HCA

Key Points

• Swiss Life Asset Management cut its stake in HCA by 12.8% in Q3, selling 4,701 shares and ending the period with 31,998 shares worth $13.64 million.
• HCA beat quarterly EPS expectations with $8.01 per share (revenue $19.51B) and set FY2026 guidance of 29.10–31.50 EPS, while analysts carry a consensus "Moderate Buy" rating and a $537.73 average price target.
• Insiders sold 15,214 shares worth about $7.8 million in the last quarter (insiders own 1.30%), and institutional investors hold 62.73% of HCA's stock.

Swiss Life Asset Management Ltd reduced its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 12.8% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 31,998 shares of the company's stock after selling 4,701 shares during the period. Swiss Life Asset Management Ltd's holdings in HCA Healthcare were worth $13,638,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Cambria Investment Management L.P. purchased a new position in HCA Healthcare during the third quarter valued at approximately $273,000. Strategic Advocates LLC purchased a new position in shares of HCA Healthcare during the 3rd quarter valued at $73,000. CIBC Private Wealth Group LLC increased its stake in shares of HCA Healthcare by 0.6% in the third quarter. CIBC Private Wealth Group LLC now owns 19,084 shares of the company's stock worth $8,134,000 after acquiring an additional 105 shares during the last quarter. Prana Capital Management LP purchased a new position in HCA Healthcare in the third quarter valued at about $1,025,000. Finally, CIBC Bancorp USA Inc. purchased a new stake in shares of HCA Healthcare during the 3rd quarter worth about $9,885,000. 62.73% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at HCA Healthcare

In other HCA Healthcare news, EVP Michael S. Cuffe sold 1,500 shares of the firm's stock in a transaction that occurred on Tuesday, February 3rd. The stock was sold at an average price of $498.09, for a total value of $747,135.00. Following the completion of the sale, the executive vice president owned 30,003 shares in the company, valued at approximately $14,944,194.27. This trade represents a 4.76% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Michael R. Mcalevey sold 1,694 shares of the company's stock in a transaction on Wednesday, February 18th. The shares were sold at an average price of $533.37, for a total value of $903,528.78. Following the completion of the transaction, the executive vice president owned 8,853 shares of the company's stock, valued at $4,721,924.61. The trade was a 16.06% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 15,214 shares of company stock worth $7,797,595. 1.30% of the stock is owned by company insiders.

HCA Healthcare Price Performance

HCA stock opened at $493.61 on Friday. The company has a 50-day moving average of $510.01 and a two-hundred day moving average of $473.08. The stock has a market capitalization of $110.36 billion, a price-to-earnings ratio of 17.39, a price-to-earnings-growth ratio of 1.53 and a beta of 1.34. HCA Healthcare, Inc. has a 52-week low of $314.43 and a 52-week high of $556.52.

HCA Healthcare (NYSE:HCA - Get Free Report) last announced its earnings results on Tuesday, January 27th. The company reported $8.01 earnings per share for the quarter, beating the consensus estimate of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The firm had revenue of $19.51 billion during the quarter, compared to the consensus estimate of $19.67 billion. During the same quarter in the prior year, the company earned $6.22 EPS. The firm's revenue for the quarter was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Equities analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th will be issued a $0.78 dividend. This is a boost from HCA Healthcare's previous quarterly dividend of $0.72. The ex-dividend date of this dividend is Tuesday, March 17th. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. HCA Healthcare's payout ratio is currently 10.99%.

Analysts Set New Price Targets

A number of equities analysts recently commented on HCA shares. Truist Financial increased their price objective on HCA Healthcare from $520.00 to $546.00 and gave the stock a "buy" rating in a report on Wednesday, January 28th. Sanford C. Bernstein set a $541.00 price target on shares of HCA Healthcare in a research note on Monday, February 9th. JPMorgan Chase & Co. lifted their price objective on shares of HCA Healthcare from $420.00 to $535.00 and gave the company a "neutral" rating in a research note on Friday, February 20th. Barclays raised their target price on HCA Healthcare from $494.00 to $551.00 and gave the company an "overweight" rating in a report on Wednesday, January 28th. Finally, Wells Fargo & Company upped their price target on HCA Healthcare from $452.00 to $481.00 and gave the stock an "equal weight" rating in a research note on Friday, January 30th. Sixteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, HCA Healthcare presently has an average rating of "Moderate Buy" and a consensus price target of $537.73.

Key HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Jim Cramer publicly recommended buying HCA, calling it a buy in “big clumps,” which can drive retail interest and short‑term inflows. Jim Cramer on HCA Healthcare
• Positive Sentiment: HCA hospitals received regional/national recognition (Ocala hospitals praised for patient safety; HCA Florida North Florida Hospital named to America’s 250 Best Hospitals), which supports brand, referrals and patient volumes. Ocala hospitals honored for excellence in patient safety
• Positive Sentiment: HCA Florida North Florida Hospital included among America’s 250 Best Hospitals, reinforcing quality credentials that can protect pricing and payer relationships. HCA Florida North Florida Hospital among America’s 250 Best Hospitals
• Positive Sentiment: Virginia regulators approved new hospitals/expansions that include HCA projects, supporting medium‑term revenue growth and market share in that region. State approves three Chesterfield hospital projects
• Neutral Sentiment: Human-interest coverage (a North Carolina NICU St. Patrick’s Day feature) highlights community care but is unlikely to move the stock materially. North Carolina NICU Celebrates St. Patrick's Day
• Negative Sentiment: HCA’s board urged shareholders to reject a proposal for fuller reporting on the aftermath of the 2019 Mission sale — a governance/oversight flashpoint that can raise investor concern and activist interest. HCA board urges shareholders to reject proposal
• Negative Sentiment: An HCA hospital CEO is leaving for Beth Israel Lahey Health — an executive departure that may be seen as local leadership turnover and could modestly concern investors about continuity in affected markets. HCA hospital CEO heads to Beth Israel Lahey Health

About HCA Healthcare

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company's core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA's services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.